Osteoporosis Drugs Linked to Esophageal Cancers Jan. 5th, 2009 at 9:18 AM Jorma Jyrkkanen

Osteoporosis Drugs Linked to Esophageal Cancers Jan. 5th, 2009 at 9:18 AM Osteoporosis Drug Linked to Cancer of the Esophagus Related Tags : news, cancer, medicine, biomedical Merck's Fosamax and generic knock-offs alendronate and Proctor and Gamble's Actonel or risedronate and Didronel or Etidronate and Roche's Boniva (Ibandronate) may be involved are all under suspicion. 6 Jan 2008 FDA's Diane Wykowski said researchers should look for potential links to eosphageal cancer from this genre of bisphosphonate osteoporosis drugs. Since Fosamax was marketed in 1995 they have had 23 reports in which patients developed esophageal tumors where eight died. She reported these concerns in a letter to the New England Journal of Medicine. There have been 21 cases in Europe of which six died. Once again we are seeing how our drug culture has after the fact side effects and not enough screening was done prior to regulatory approval. Better osteoporosis than this. Pop culture often encourages us to be paranoid about our health and then we find that the cure is worse than the disease. Vitamins were the same. It has been found that taking vitamins actually reduces life expectancy (See http://news.bbc.co.uk/2/hi/7349980.stm).